Literature DB >> 3818588

Fibronectin gene expression in polymorphonuclear leukocytes. Accumulation of mRNA in inflammatory cells.

M La Fleur, A D Beaulieu, C Kreis, P Poubelle.   

Abstract

Using a fibronectin cDNA probe, we have studied the accumulation of fibronectin mRNA in polymorphonuclear leukocytes (PMN) in response to inflammation. Nonactivated PMN from human peripheral blood were used as a source of noninflammatory cells and PMN from inflamed knee joints of patients with chronic inflammatory joint disorders (rheumatoid and psoriatic arthritis) were used as a source of inflammatory cells. By dot blot and Northern hybridization analysis, we have found the presence of fibronectin mRNA in these cells. Its size was estimated at approximately equal to 8.7-8.8 kilobases. When noninflammatory PMN were compared to inflammatory PMN in terms of fibronectin mRNA accumulation, a marked increase was found in inflammatory cells (2- to 12.7-fold stimulation). It was also observed that the increased mRNA levels in inflammatory PMN lead to increased synthesis of the protein. These findings establish that PMN are part of the fibronectin-producing cells and that the level of mRNA in these cells is influenced by the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3818588

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Characterization of the alpha 4 integrin gene promoter.

Authors:  G D Rosen; T M Birkenmeier; D C Dean
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Differential effects of cell density on 5-lipoxygenase (5-LO), five-lipoxygenase-activating protein (FLAP) and interleukin-1 beta (IL-1 beta) expression in human neutrophils.

Authors:  C Jobin; J Gauthier
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

3.  Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall.

Authors:  A R Huber; S J Weiss
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes.

Authors:  P C Lord; L M Wilmoth; S B Mizel; C E McCall
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Rapid extraction of high molecular weight RNA from cultured cells and granulocytes for Northern analysis.

Authors:  H C Birnboim
Journal:  Nucleic Acids Res       Date:  1988-02-25       Impact factor: 16.971

6.  Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies.

Authors:  S R Maxfield; K Moulder; F Koning; A Elbe; G Stingl; J E Coligan; E M Shevach; W M Yokoyama
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

7.  Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis.

Authors:  Marzia Dolcino; Andrea Ottria; Alessandro Barbieri; Giuseppe Patuzzo; Elisa Tinazzi; Giuseppe Argentino; Ruggero Beri; Claudio Lunardi; Antonio Puccetti
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

8.  High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.

Authors:  Wenzhong Yi; Enhua Xiao; Ru Ding; Ping Luo; Yi Yang
Journal:  Oncol Rep       Date:  2016-10-17       Impact factor: 3.906

9.  Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells.

Authors:  Marcello Monti; Francesca Iommelli; Viviana De Rosa; Maria Vincenza Carriero; Roberta Miceli; Rosa Camerlingo; Giovanni Di Minno; Silvana Del Vecchio
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

10.  Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.

Authors:  S R McColl; R Paquin; C Ménard; A D Beaulieu
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.